CMS Proposal For Carotid Stenting Coverage Gives A Little, Takes A Little
This article was originally published in The Gray Sheet
Executive Summary
CMS' proposed revision to its carotid artery stenting Medicare coverage policy is a mixed blessing for manufacturers eager to reach more patients
You may also be interested in...
CMS Backs Away From Expanding Carotid Stenting Coverage
CMS has reversed its earlier proposal to significantly expand coverage of carotid stenting, dampening industry's hopes for a more open U.S. carotid stent market in the near term
CMS Backs Away From Expanding Carotid Stenting Coverage
CMS has reversed its earlier proposal to significantly expand coverage of carotid stenting, dampening industry's hopes for a more open U.S. carotid stent market in the near term
Carotid Stenting Coverage Decision Should Discount “Flawed” European Data
Manufacturers say CMS' proposed coverage policy for carotid stenting, which includes only part of the FDA-approved indication, is based on data that do not reflect current medical practice in the United States